Detalhe da pesquisa
1.
Phase 1 trial of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced non-small cell lung cancer.
Lung Cancer
; 182: 107291, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423058
2.
HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans.
Clin Cancer Res
; 28(24): 5405-5418, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36190432
3.
Better Late Than Never: Fully Incorporating Oncology Advanced Practice Providers Into Cancer Clinical Trials.
JCO Oncol Pract
; 18(11): 729-732, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35960907